Certara’s Model-Informed Drug Development (MIDD) approach leverages an integrated, quantitative systems methodology to accelerate regulatory approval and commercial success while minimizing time and costs. With a global team of 700+ experts in clinical pharmacology, pharmacometrics, regulatory strategy, and market access, we provide the expertise and dedication needed to help you achieve your goals.
Learn more about services to progress your drug or therapy to the next stage
View ServicesDownload Rescue Story Volume 2
Get in touch with Certara’s team
Certara’s team is ready to support your drug development needs. 无论您需要先导化合物优化、IND 申报准备,还是高级建模解决方案,我们的专家团队将全程为您提供指导。